Parenteral Excipients

GELITA has launched an ultra low endotoxin gelatin, specified at less than 10 endotoxin units (EU) per gram, for sensitive...

Amphiphilic, non-ionic block copolymers suitable for diverse pharmaceutical applications Did you know? Kolliphor® P grade poloxamers are among the most...

Abstract In vitro/in vivo correlation (IVIVC) is of great importance to expedite the development life-cycles for pharmaceutical industry and possibly to...

See our next Live Webinar on the topic of: Lipid-based formulations and enteric capsules to enhance oral bioavailability of peptides...

See our next webinar on the topic of: Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug...

Abstract Long acting injectable (LAI) suspensions represent a promising drug delivery platform, offering a number of advantages such as sustained...

See the new book, edited by Hannah Batchelor and Klaus Rose. Pediatric Formulations A Roadmap   Written in cooperation with...

Abstract Parenteral therapies are vital in critical care, oncology, and nutrition, offering rapid onset, precise dosing, and high bioavailability. However,...

Abstract High dose biologic drug products (DPs) have become a common trend for the treatment of chronic diseases across a...

Our Mineral Salts in low endotoxin quality are produced under stringent GMP standards including low endotoxin process water. This unique...